Delivery Order SPE2DB22D3501-SPE2DB23FVG76

Award Date 4/14/23
Potential Completion Date 4/17/23
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,340.24 firm fixed-price delivery order is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a pharmaceutical product, with an ultimate completion date of February 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $3,156.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML. The award, valued at $2,634.82, is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a total completion date of June 11, 2024. Amerisourcebergen is the prime contractor, and there is no indication of any set-aside requirements for this...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,126.91, is a Firm Fixed Price Delivery Order for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical product. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,249.79, is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical commodity. The contract has a firm fixed price pricing type and a completion date of January 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,449.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of DIPRIVAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans'...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,292.32 firm fixed-price delivery order is for the supply of 4,566,717,536 units of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical anesthesia medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.88 firm fixed-price delivery order is for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML medical products. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $4,335.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of "DIPRIVAN 500 MG/50 ML VIAL 50ML", a critical medical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML. The contract has a ceiling value of $12,297.32 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities from...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB23FVG76
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,291.22, is a delivery order for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML medical products. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience in federal healthcare contracting and its ability to reliably supply critical medical commodities to the Defense Department and other government agencies have made it a key vendor for the DLA.

Generated 5/9/25, 10:17 AM